🇺🇸 FDA
Pipeline program

ETR028, ETR029, [ETR028 + ETR029] or HCBT

O2P-001

Phase 1 small_molecule active

Quick answer

ETR028, ETR029, [ETR028 + ETR029] or HCBT for Acute Pain is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Acute Pain
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials